Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey | Zendy

Gregory Lip | Zendy; M G Bongiorni | Zendy; Dan Dobreanu | Zendy; T. Lewalter | Zendy; Jesper Hastrup Svendsen | Zendy; Carina BlomströmLundqvist | Zendy

Open Access

Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey

Author(s) -

Gregory Lip,

M G Bongiorni,

Dan Dobreanu,

T. Lewalter,

Jesper Hastrup Svendsen,

Carina BlomströmLundqvist

Publication year - 2013

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eut292

Subject(s) - medicine , atrial fibrillation , heart rhythm , guideline , stroke (engine) , cardiology , clinical practice , intensive care medicine , physical therapy , pathology , mechanical engineering , engineering

The purpose of this European Heart Rhythm Association (EHRA) survey was to assess clinical practice in relation to stroke prevention in atrial fibrillation (AF), particularly into the use of novel oral anticoagulants (NOACs) for stroke prevention, among members of the EHRA electrophysiology (EP) research network. In this EP Wire survey, we have provided some insights into current practice in Europe for the use of NOACs for stroke prevention in AF. There were clear practice differences evident, and also the need for greater adherence to the guidelines, especially since guideline adherent management results in better outcomes in AF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research